Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data

BACKGROUND: Few studies have evaluated survival, treatment, resource use, and costs among women with stage IV ER + breast cancer (BC) who did not receive HER2 targeted therapy. METHODS: Using linked Surveillance, Epidemiology, and End Results (SEER) and Medicare data from 2006-2009, women aged 66+ y...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Kathleen, Huang, Huan, Sasane, Medha, Federico Paly, Victoria, Hao, Yanni, Menzin, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097046/
https://www.ncbi.nlm.nih.gov/pubmed/25008431
http://dx.doi.org/10.1186/1472-6963-14-298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097046/
https://www.ncbi.nlm.nih.gov/pubmed/25008431
http://dx.doi.org/10.1186/1472-6963-14-298

Ejemplares similares